RL
HRMY icon

Ruffer LLP’s Harmony Biosciences HRMY Stock Holding History

Ruffer LLP’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-104,658
Closed -$2.94M – 201
2026
Q1 		$2.94M Buy
104,658
+63,665
+155% +$2.09M 0.12% 119
2025
Q4 		$1.54M Buy
+40,993
New +$1.35M 0.07% 131
2025
Q3 		– Sell
-86,211
Closed -$2.72M – 116
2025
Q2 		$2.72M Buy
+86,211
New +$2.77M 0.12% 80
2025
Q1 		– Sell
-75,501
Closed -$2.6M – 112
2024
Q4 		$2.6M Buy
+75,501
New +$2.59M 0.09% 85

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ruffer LLP's HRMY Position: Q2 2026 in Review

Ruffer LLP sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 104,658 shares — an estimated $2.94M sold.

Ruffer LLP first reported a position in HRMY in Q4 2024 and held it in 4 quarters. The position peaked at $2.94M in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Ruffer LLP reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Ruffer LLP sold 104,658 Harmony Biosciences shares in Q2 2026, an estimated $2.94M.
  • Ruffer LLP first reported a position in Harmony Biosciences in Q4 2024 and held it in 4 quarters.
  • Ruffer LLP's Harmony Biosciences position peaked at $2.94M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Ruffer LLP's 13F filing for Q2 2026, filed 30 Jul 2026.